Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Linde (Jerusalem, Israel). Regulation of the response to stop mutation read-through by the nonsense mediated decay mechanism. Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?

Member's Comments

No comment yet.

Related content which might interest you: Rescue of CFTR function impaired by mutations in exon 15 Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required? Source: Eur Respir J 2014; 44: 269-270 Year: 2014 Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required? Source: Eur Respir J 2014; 44: 270-271 Year: 2014 Mutation and functional analysis of the IL-18 promoter in sarcoidosis: a potential role for single nucleotide polymorphisms in cytokine expression regulation Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003 Sarcoidosis is associated with a truncating splice site mutation in the BTNL2 gene Source: Eur Respir J 2005; 26: Suppl. 49, 468s Year: 2005 BMPR2 gene delivery shifts intracellular Smad activation profile Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Interleukin-6: potential new function and regulation through alternative splicing Source: Eur Respir J 2001; 18: Suppl. 33, 476s Year: 2001 Methylprednisolone pulse treatment influences splicing of SFTPC mRNA and promotes processing of pro-SP-C protein in twins with SFTPC mutation Source: International Congress 2018 – Orphan diseases in children Year: 2018 Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation Source: Eur Respir J 2004; 24: 1072-1073 Year: 2004 T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease Source: Annual Congress 2011 - T-cell subsets Year: 2011 Enhanced efficiency of phenotypic transition of asthmatic fibroblasts depends on canonical and non-canonical TGFß/Smad signaling pathways Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator Source: Eur Respir J, 57 (6) 2002774; 10.1183/13993003.02774-2020 Year: 2021 Common IRF1 promoter polymorphisms induce changes in transcription factor binding subsequently affecting IRF1 gene expression Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008 Regulatory effect of cadmium on inflammasome activation and and its upstream mechanisms Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology Year: 2020 Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons Source: ERJ Open Res, 4 (1) 00080-2017; 10.1183/23120541.00080-2017 Year: 2018 Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001 Modification of gene expression and increase in alpha-1-antitrypsin (α1AT) secretion after homologous recombination in α1AT deficient monocytes Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007 Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth in vivo by retrovirus-mediated gene transfer Source: Annual Congress 2002 - Thoracic oncology: biology Year: 2002 Target other gene point mutations: HER2 and rare EGFR mutations Source: ERS Research Seminar Year: 2015 Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011